Medindia

X

Brazil's Non-Small-Cell Lung Cancer Drug Market will Reach $240 Million by 2014

Tuesday, July 6, 2010 General News J E 4
Advertisement
Eli Lilly and Roche Dominated the Non-Small-Cell Lung Cancer Drug Market in Brazil in 2009, According to a New Report from Decision Resources

For more information, contact:

Christopher Comfort

Decision Resources

781-296-2597

ccomfort@dresources.com

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Cornerstone Therapeutics Reacquires HMGB1 Protein ...
S
NeoStem Named 'Best Stem Cell Company' in The New ...